# China Cinda Asset Management

> China Cinda Asset Management is a VC fund in Beijing backing Energy and Manufacturing. See 16 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 16
- Last investment: Jul 2026
- Lead investor: 19%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/china-cinda-asset-management/about/
- Website: http://www.cinda.com.cn

China Cinda Asset Management is a VC fund in Beijing focused on Energy and Manufacturing. China Cinda Asset Management Ltd. known as China Cinda or just Cinda is a Chinese merchant bank and asset management company. The corporation was founded as a state-owned enterprise and a bad bank for China Construction Bank in 1999

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Energy | 3 | 19% |
| Manufacturing | 3 | 19% |
| Solar | 2 | 13% |
| Biopharma | 2 | 13% |
| Biotechnology | 2 | 13% |

42 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 4 | 25% |
| Series C | 3 | 19% |
| Venture - Series Unknown | 3 | 19% |
| Series A | 2 | 13% |
| Angel | 1 | 6% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 13 | 81% |
| Israel | 1 | 6% |
| Singapore | 1 | 6% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Hangzhou Modi Digital Technology | Hangzhou Modi Digital Technology is dedicated to provide government and business clients complete digital transformation solutions via a "core technology + solutions + ecosystem cooperation model." | $3M | Series B | Jul 28, 2026 |  |
| Nanjing Luye Pharma | Nanjing Luye is a subsidiary of the Luye Pharma Group, which manufactures and sells pharmaceuticals, notably oncology therapies. |  | Venture - Series Unknown | Mar 10, 2026 |  |
| Yantai Lannacheng Biotechnology | Yantai Lannacheng Biotechnology is a biotech business that focuses on the building class I diagnosis and therapy integrated novel tumor nuclear medication research and development platform.and therapy integrated novel tumor nuclear medication research and development platform. | $41.8M | Series C | Jul 20, 2025 |  |
| GCL Optoelectronics | GCL Optoelectronics is a supplier of perovskite solar modules, focusing on the R&D and production of perovskite solar modules. | $27.8M | Series C | Jun 11, 2025 |  |
| AECC Commercial Aircraft Engine | AECC offers design, development, production, assembly, testing, and technical consulting of commercial aircraft power services. |  | Series A | Jun 06, 2025 |  |
| Sidson Industries | Sidson Industries is a manufacturer and supplier of industrial control, electronic components and systems. | $6.9M | Angel | Apr 03, 2025 |  |
| Zhilong New Materials | Zhilong New Materials is a Sino-foreign joint venture semiconductor material innovation enterprise that researches, produces, and sells semiconductor display sputtering targets and semiconductor photovoltaic targets. |  | Series A | Dec 31, 2024 |  |
| Zhejiang JinkoSolar | Zhejiang JinkoSolar is a clean energy solutions company that develops, manufactures and sales of high-efficiency solar cells and modules. It is a wholly-owned subsidiary of JinkoSolar. |  | Venture - Series Unknown | Sep 13, 2024 |  |
| Zhongning Silicon | Zhongning Silicon is a manufacturer of semiconductors, liquid crystals, and photovoltaics. | $112.3M | Venture - Series Unknown | Jan 04, 2024 |  |
| Kelun Biotech | Kelun Biotech is a biopharmaceutical company.It focuses on the research and development, production and sales of innovative drugs | $200M | Series B | Dec 29, 2022 |  |

10 of 16 investments shown.

## Co-investors
- Chengtong Mixed Reform — VC Fund, 2 deals together
- Aegon Industrial Fund Management Co. — VC Fund, 1 deal together
- [Aviation Development Fund](https://shizune.co/investors/profile/aviation-development-fund) — VC Fund, 1 deal together
- [Bank of China Financial Assets Investment](https://shizune.co/investors/profile/bank-of-china-financial-assets-investment) — VC Fund, 1 deal together
- Beijing Daying Investment Development — VC Fund, 1 deal together
- Beijing State-owned Assets Management Co. — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does China Cinda Asset Management invest in?

China Cinda Asset Management invests primarily in Energy, Manufacturing and Solar startups, most often at Series B and Series C stage. Most of the 16 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did China Cinda Asset Management last invest?

The most recent investment recorded for China Cinda Asset Management closed in Jul 2026. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co